Pulmonary Hypertension in Neonates: Inhaled Nitric Oxide vs Epoprostenol (Flolan)

ثبت نشده
چکیده

J Lung Pulm Respir Res 2016, 3(3): 00082 selectively targets pulmonary vessels, causing a potent and sustained vasodilatation, and therefore increasing pulmonary blood flow [2]. After diffusion across the alveolar capillary membrane, the iNO is absorbed by subjacent smooth muscles of the pulmonary vasculature to activate soluble guanylate cyclase, which is responsible for conversion of GTP to cGMP which activates relaxation of smooth muscles via several mechanisms [2]. Because iNO is scavenged and deactivated by the hemoglobin upon diffusion into the blood, its vasodilatory effects are limited largely to the lungs [2].

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Comparison of acute hemodynamic effects of inhaled nitric oxide and inhaled epoprostenol in patients with pulmonary hypertension

Inhaled nitric oxide (iNO) is used for acute vasoreactivity testing in pulmonary arterial hypertension (PAH) patients. Inhaled epoprostenol (iPGI2) has pulmonary selectivity and is less costly. We sought to compare acute hemodynamic effects of iNO (20 ppm) and iPGI2 (50 ng/kg/min) and determine whether their combination has additive effects. We conducted a prospective, single center, randomized...

متن کامل

Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment.

BACKGROUND Continuous intravenous treatment with epoprostenol significantly improves pulmonary haemodynamics and survival in patients with primary pulmonary hypertension (PPH). Its beneficial effect, however, may be blunted due to adverse effects such as catheter sepsis and systemic hypotension. Recent investigations have shown that inhaled iloprost is effective in the treatment of PPH. Based o...

متن کامل

Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a chronic, progressive disease of the pulmonary vasculature with a high morbidity and mortality. Its pathobiology involves at least three interacting pathways - prostacyclin (PGI(2)), endothelin, and nitric oxide (NO). Current treatments target these three pathways utilizing PGI(2) and its analogs, endothelin receptor antagonists, and phosphodiesterase t...

متن کامل

Inhaled alternatives to nitric oxide.

OBJECTIVE Inhaled nitric oxide has gained an established place in the management of pulmonary hypertension. However, cost, potential toxicity, and the lack of positive outcome data with inhaled nitric oxide therapy has generated interest in alternative inhaled, selective pulmonary vasodilators. This article describes those alternatives that have been studied to date. DESIGN Literature review ...

متن کامل

Clinical trials of inhaled nitric oxide therapy in the newborn.

1. Describe the benefits of inhaled nitric oxide in the treatment of persistent pulmonary hypertension of the newborn. 2. Determine the range of appropriate initial doses of inhaled nitric oxide therapy for term neonates. 3. Delineate the potential role of inhaled nitric oxide in conjunction with extracorporeal membrane oxygenation. 4. Describe the lung-specific effects of low-dose inhaled nitr...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2016